Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study

OBJECTIVES: To prospectively validate that the inability to decrease procalcitonin levels by more than 80% between baseline and day 4 is associated with increased 28-day all-cause mortality in a large sepsis patient population recruited across the United States. DESIGN: Blinded, prospective multicen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Crit Care Med
Main Authors: Schuetz, Philipp, Birkhahn, Robert, Sherwin, Robert, Jones, Alan E., Singer, Adam, Kline, Jeffrey A., Runyon, Michael S., Self, Wesley H., Courtney, D. Mark, Nowak, Richard M., Gaieski, David F., Ebmeyer, Stefan, Johannes, Sascha, Wiemer, Jan C., Schwabe, Andrej, Shapiro, Nathan I.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2017
Assuntos:
Feature Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5389588/
https://ncbi.nlm.nih.gov/pubmed/28257335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCM.0000000000002321
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados